Metrics That Reveal Whether You’re Investing From Strength or Stretch
CapEx decisions don’t happen in isolation—they’re shaped by the financial health of the enterprise. Whether you’re justifying a kiln rebuild or pitching a digital upgrade, understanding key health indicators is crucial to timing and scope. These aren’t just for the CFO—every CapEx sponsor should know them.
Top Indicators That Guide Investment Readiness
Free Cash Flow (FCF)
Measures internal capacity to fund projects. A negative FCF may push the business toward leasing, deferral, or staged execution.
Return on Capital Employed (ROCE)
Reflects how efficiently current capital is performing. High ROCE justifies further investment; declining ROCE may signal misallocation.
Debt-to-EBITDA Ratio
High ratios can trigger covenant limits, making board approvals more conservative—even for high-ROI projects.
CapEx-to-Sales Ratio
Helps benchmark investment intensity. For mature facilities, <3% may suffice; for expansion mode, 7–10% is typical.
Cash Conversion Cycle
Long cycles (inventory-heavy, slow receivables) may slow reinvestment—even if demand justifies it.
How to Use These Metrics Strategically
Tie them directly into CapEx proposals—demonstrate alignment with financial goals
Flag which indicators the project will improve (e.g., reduced OPEX enhances FCF)
Track health quarterly to time major projects with strength, not stretch
Conclusion
Capital planning doesn’t start with an equipment list—it starts with financial fluency. When planners understand liquidity, leverage, and asset productivity, they earn faster approvals and drive smarter investment outcomes.
